IDM Pharma announced updated results from a Phase 2 UVIDEM (IDD-3) melanoma vaccine clinical trial (DC-MEL-202).
Ads by Google
International Melanoma Congress signals new promise and hope in treating a disease that has long held a dismal prognosis for those in the advanced stages. Caught early, melanoma is one of the easiest cancers to treat, but caught late, melanoma is one of the most incurable and deadly.
A landmark publication on Melanoma that appeared in the Journal of Investigative Dermatology reports the results of a large, two site blinded clinical study.
Once every two hours a Florida resident is diagnosed with a new case of melanoma skin cancer.
California dermatologist is working to decrease this alarming statistic, and increase the likelihood that local residents diagnosed with this deadliest type of skin cancer will survive.
The farther patients travel to reach the physician who diagnoses their melanoma, the more likely they are to have thicker skin cancer at diagnosis.
What causes skin cancer and why it usually is diagnosed in its fatal stages among blacks is something of a mystery.
Monitoring moles and looking for changes on a regular basis is key to early detection and treatment of melanoma.
Microarray technology, now makes it possible to more definitively identify skin lesions in mice that are thought to be at high risk of progressing to a type of cancer known as squamous cell carcinoma (SCC).